← Back to Search

Procedure

Dynamic Coronary Roadmap group for Coronary Artery Disease (DCR4Contrast Trial)

N/A

Waitlist Available

Led By Javier Escaned, MD

Research Sponsored by Philips Healthcare

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during percutaneous coronary intervention (pci) procedure

Awards & highlights

DCR4Contrast Trial Summary

This trial is testing whether a software medical device called the Dynamic Coronary Roadmap can help reduce the amount of contrast dye used during a common heart procedure called percutaneous coronary intervention (PCI). The trial is comparing the use of the device to the standard care without the device.

DCR4Contrast Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during percutaneous coronary intervention (pci) procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during percutaneous coronary intervention (pci) procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and during percutaneous coronary intervention (pci) procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Total Percutaneous Coronary Intervention (PCI) Iodinated Contrast Volume

Secondary outcome measures

Number of Angiograms

DCR4Contrast Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Dynamic Coronary Roadmap groupExperimental Treatment1 Intervention

Patients will be treated via standard of care for Percutaneous Coronary Intervention (PCI) with navigation support of Dynamic Coronary Roadmap.

Group II: Control groupActive Control1 Intervention

Patients will be treated via standard of care for Percutaneous Coronary Intervention (PCI) without navigation support of Dynamic Coronary Roadmap.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Percutaneous Coronary Intervention (PCI) with Dynamic Coronary Roadmap

2019

N/A

~380

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Philips HealthcareLead Sponsor

125 Previous Clinical Trials

281,955 Total Patients Enrolled

2 Trials studying Coronary Artery Disease

281 Patients Enrolled for Coronary Artery Disease

Philips Clinical & Medical Affairs GlobalLead Sponsor

49 Previous Clinical Trials

16,167 Total Patients Enrolled

1 Trials studying Coronary Artery Disease

3,212 Patients Enrolled for Coronary Artery Disease

Javier Escaned, MDPrincipal InvestigatorSan Carlos Hospital Madrid

3 Previous Clinical Trials

3,772 Total Patients Enrolled

2 Trials studying Coronary Artery Disease

2,954 Patients Enrolled for Coronary Artery Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit of participants for this research endeavor?

"Affirmative. Data hosted on clinicaltrials.gov conveys that this experiment, which was published on October 1st 2019, is still open for recruitment. Approximately 394 research subjects must be sourced from 2 trial sites."

Answered by AI

Is the enrollment period for this clinical trial still open?

"Affirmative. On clinicaltrials.gov, the information suggests that this research is actively looking for participants; first posted on October 1st 2019 and last updated June 27th 2022. They need 394 individuals to be enrolled from 2 different medical facilities."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Dynamic Coronary Roadmap for Contrast Reduction

2019. "Dynamic Coronary Roadmap for Contrast Reduction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04085614.